129 related articles for article (PubMed ID: 21068100)
1. The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study.
Becker MO; Brückner C; Scherer HU; Wassermann N; Humrich JY; Hanitsch LG; Schneider U; Kawald A; Hanke K; Burmester GR; Riemekasten G
Ann Rheum Dis; 2011 Jul; 70(7):1340-1. PubMed ID: 21068100
[No Abstract] [Full Text] [Related]
2. Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.
Scherer HU; Burmester GR; Riemekasten G
Ann Rheum Dis; 2006 Sep; 65(9):1245-7. PubMed ID: 16905582
[No Abstract] [Full Text] [Related]
3. CD25 blockade for refractory polymyositis.
Pipitone N; Salvarani C
Clin Exp Rheumatol; 2013; 31(3):474. PubMed ID: 23465197
[No Abstract] [Full Text] [Related]
4. Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody.
Chakupurakal G; García-Márquez MA; Shimabukuro-Vornhagen A; Theurich S; Holtick U; Hallek M; Scheid C; von Bergwelt-Baildon M
Eur J Haematol; 2016 Aug; 97(2):121-7. PubMed ID: 26492560
[TBL] [Abstract][Full Text] [Related]
5. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
[TBL] [Abstract][Full Text] [Related]
6. [Chimeric anti-CD25 antibody in the treatment of refractory fulminating ulcerative colitis].
Oliver-Goicolea P; Irastorza-Terradillos I; Vitoria-Cormenzana JC
An Pediatr (Barc); 2011 May; 74(5):340-1. PubMed ID: 21382757
[No Abstract] [Full Text] [Related]
7. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a patient with myasthenia gravis using antibodies against CD25.
Kakoulidou M; Pirskanen-Matell R; Lefvert AK
Acta Neurol Scand; 2008 Mar; 117(3):211-6. PubMed ID: 17877770
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
11. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.
Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A
Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329
[TBL] [Abstract][Full Text] [Related]
12. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
[TBL] [Abstract][Full Text] [Related]
13. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.
Kandus A; Arnol M; Omahen K; Oblak M; Vidan-Jeras B; Kmetec A; Bren AF
Transplantation; 2010 Apr; 89(8):1022-7. PubMed ID: 20075788
[TBL] [Abstract][Full Text] [Related]
14. Quantification of circulating regulatory T cells by flow cytometry in kidney transplant patients after basiliximab induction therapy.
Abadja F; Alamartine E; Berthoux F; Mariat C; Genin C; Lambert C
Transplantation; 2010 Feb; 89(3):366-8. PubMed ID: 20145530
[No Abstract] [Full Text] [Related]
15. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
[TBL] [Abstract][Full Text] [Related]
16. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
Denton CP; Engelhart M; Tvede N; Wilson H; Khan K; Shiwen X; Carreira PE; Diaz Gonzalez F; Black CM; van den Hoogen FH
Ann Rheum Dis; 2009 Sep; 68(9):1433-9. PubMed ID: 18782794
[TBL] [Abstract][Full Text] [Related]
17. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody.
Praditpornsilpa K; Avihingsanon Y; Kupatawintu P; Songpanich S; Pisitkul T; Kansanabuch T; Eiam-Ong S; Chusil S; O-Charoen R; Tungsanga K
Transplant Proc; 2004 Mar; 36(2 Suppl):487S-491S. PubMed ID: 15041394
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on anti-CD25: daclizumab in MS.
Schippling DS; Martin R
Int MS J; 2008 Sep; 15(3):94-8. PubMed ID: 18808743
[TBL] [Abstract][Full Text] [Related]
20. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
